Laureate Education

LAUR · NASDAQ

$38.96−$0.34 (−0.87%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $39.30

LAUR analyst rating

HoldConsensus of 4 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy2
Hold1
Underperform1
Sell0

12-month price target · 9 analysts

Average $42.08 (+8.0% upside)

Low: $34.85
Now: $38.96
High: $47.25

Upgrades and downgrades

The latest rating actions, newest first

LAUR analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Oct 15, 2026	Maintains	Underweight	$34.50 → $36.50	50%
JP Morgan	Aug 3, 2026	Downgrade	Overweight → Neutral	$41.00	64%
JP Morgan	Jun 4, 2026	Maintains	Overweight	$41.50 → $41.00	64%
UBS	May 1, 2026	Maintains	Buy	$37.50 → $39.00	71%
BMO Capital	Mar 26, 2026	Maintains	Outperform	$40.00 → $43.00	60%
JP Morgan	Mar 11, 2026	Maintains	Overweight	$40.00 → $41.50	64%
UBS	Feb 24, 2026	Maintains	Buy	$39.00 → $37.50	71%
BMO Capital	Feb 23, 2026	Maintains	Outperform	$36.00 → $40.00	60%
Morgan Stanley	Feb 18, 2026	Maintains	Equal-Weight	$32.00 → $36.50	50%
UBS	Jan 8, 2026	Maintains	Buy	$36.00 → $39.00	71%

The case for and against

Updated Oct 23, 2025

Bull case

Laureate Education Inc. has demonstrated positive enrollment trends, with a 6% increase in new students in Peru and an 8% rise in Mexico, prompting management to revise guidance upwards based on improved visibility. The company's ability to achieve these growth rates, particularly in Mexico's secondary intake period, underscores its resilience in a competitive market. The strategic focus on expanding its international presence and enhancing its educational offerings positions Laureate Education favorably for sustained growth in the higher education sector.

Bear case

Laureate Education Inc. is facing a negative outlook primarily due to a projected decline in earnings per share (EPS), with estimates anticipated to be 10% lower than previously forecasted. Additionally, the company reported a consistently low adjusted EBITDA margin of only 2.3%, indicating potential operational inefficiencies or profitability challenges. Furthermore, the revenue per enrollment has shown a year-over-year decline, exacerbated by timing issues, which could hinder future growth prospects.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.